IP Library › Granted Patent US 7,309,468
Granted Patent B2
US 7,309,468 · App. 10/436,263 · Granted Dec 18, 2007

Protease inhibitor sample collection system

Assignee: Becton, Dickinson and Company
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,309,468
App. No.
10/436,263
Granted
Dec 18, 2007
Kind
B2
Abstract

A collection container and a method for collecting a biological sample, particularly whole blood, that includes at least one stabilizing agent in an amount effective to stabilize and inhibit protein degradation and/or fragmentation. The stabilizing agent is able to stabilize proteases in the biological sample, particularly at the point of collection, by inhibiting protein degradation and/or fragmentation in the sample when the sample is stored. The stabilizing agent includes one or more protease inhibitors.

Claims (25)

1. A sterile and evacuated tube for collecting and stabilizing whole blood or a component thereof, comprising a first end and a second end and at least one interior wall defining a reservoir portion for receiving the blood, wherein said reservoir comprises a separating element and a protein stabilization agent comprising at least two lyophilized protease inhibitors, wherein a first inhibitor is an inhibitor of a serine protease and a second inhibitor is an inhibitor of another class of protease; and a closure piercable by a needle for supplying blood to said reservoir.

2. The tube of claim 1 , wherein the interior wall comprises plastic or glass.

3. The tube of claim 1 , wherein said reservoir comprises more than two lyophilized protease inhibitors.

4. The tube of claim 1 , or claim 3 wherein the lyophilized protease inhibitors comprise at least two inhibitors of a serine protease and at least one inhibitor of a cysteine protease.

5. The tube of claim 1 , or claim 3 wherein the lyophilized protease inhibitors comprise at least one inhibitor of a serine protease, at least one inhibitor of a cysteine protease, and an inhibitor of a cysteine/serine protease.

6. The tube of claim 1 , or claim 3 wherein the lyophilized protease inhibitors comprise at least one inhibitor of a serine protease, at least one inhibitor of a cysteine protease, and at least one of an inhibitor of a cysteine/serine protease, an inhibitor of an aspartic protease, an inhibitor of a metalloprotease, and an inhibitor of an exopeptidase.

7. The tube of claim 6 , wherein said inhibitor of a serine protease is selected from the group consisting of AEBSF, aprotinin, antithrombin, elastatinal, leupeptin, APMSF, DFP and trypsin, and mixtures thereof.

8. The tube of claim 7 , wherein said inhibitor of a serine protease comprises AEBSF, aprotinin and leupeptin.

9. The tube of claim 7 , wherein said at least two lyophilized protease inhibitors comprise AEBSF in a concentration of less than 1 mM at whole blood volume of the collected blood or component thereof.

10. The tube of claim 6 , wherein said inhibitor of a cysteine protease is E-64.

11. The tube of claim 6 , wherein said inhibitor of a cysteine/serine protease is selected from the group consisting of leupeptin, TPCK, TLCK-HCl (L-1-chloro-3-[4-tosylamido]-7-amino-2-heptanone-HCl), and antipain-HCl, and mixtures thereof.

12. The tube of claim 6 , wherein said inhibitor of an aspartic protease is selected from the group consisting of calpain, N-acetyl-leu-leu-norleucinal, N-acetyl-leu-leu-methioninal, pepstatin and VdLPFFVdL, and mixtures thereof.

13. The tube of claim 6 , wherein said inhibitor of a metalloprotease is selected from the group consisting of EDTA, 1,10-phenanthroline, phosphoramodon and mixtures thereof.

14. The tube of claim 6 , wherein said inhibitor of an exopeptidase is selected from the group consisting of amastatin, bestatin, diprotin A and diprotin B, and mixtures thereof.

15. The tube of claim 1 , or claim 3 wherein said separating element comprises a gel composition.

16. The tube of claim 15 , wherein said gel composition comprises a thixotropic gel.

17. The tube of claim 15 , wherein said gel composition is contained in a capsule.

18. The tube of claim 1 , or claim 3 wherein said separating element comprises a mechanical separating element.

19. The tube of claim 1 , or claim 3 further comprising an anticoagulant.

20. The tube of claim 19 , wherein said anti-coagulant is spray-dried onto at least a portion of an anterior wall of the tube.

21. The tube of claim 19 , wherein said anticoagulant comprises EDTA or a salt thereof.

22. The tube of claim 19 , wherein said anticoagulant comprises heparin.

23. The tube of claim 1 , or claim 3 further comprising collected blood.

24. The tube of claim 1 , or claim 3 further comprising a component of whole blood.

25. The tube of claim 24 , wherein said component of whole blood comprises serum or plasma.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2007
From: HAYWOOD, BRUCE; DASTANE, AJIT N; LIN, FU-CHUNG
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 020239/0598 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2007
From: HAYWOOD, BRUCE
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 020126/0855 →
Continuity (2)
Provisional Application 6037939900 · May 13, 2002
Related Publication 20040013575A1 · Jan 22, 2004